Lupin spins out two oncology programs to Kaveri Therapeutics to advance its oncology strategy Read more
Large pharma drug licensing from China reaches record high at 28 per cent in 2024, reveals GlobalData Read more
Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001 Read more